|
Monday, February 28 — 8:00 AM — Convention Center Room 206
Click on the numbers in parentheses to display abstracts.
Section E - BREAST PATHOLOGY
Chaired by: Christopher Elston and Melinda Sanders
| 8:00 |
Outcome of Patients with Ductal Carcinoma In Situ (DCIS) "Treated" by Diagnostic Biopsy Alone: Results from the Nurses' Health Study
(123)
LC Collins, RM Tamimi, H Baer, JL Connolly, GA Colditz, SJ Schnitt - Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Harvard School of Public Health; Boston, MA
|
| 8:15 |
Tumor Type and Nottingham Grade of Invasive Carcinoma Following Atypical Lobular Hyperplasia on Initial Breast Biopsy
(182)
BK McLaren, PA Schuyler, M Sanders, RA Jensen, JF Simpson, WD Dupont, DL Page - Vanderbilt University Medical Center, Nashville, TN
|
| 8:30 |
Are Synchronous Atypical Ductal Hyperplasia and Atypical Lobular Hyperplasia (Which Are Common) Genetically Related?
(189)
SK Mohsin, F Arbab, DC Allred - Baylor College of Medicine, Houston, TX
|
| 8:45 |
Pleomorphic Apocrine Lobular Carcinoma In Situ (PALCIS): Phenotypic and Genetic Study of a Distinct Variant of Lobular Carcinoma In Situ (LCIS)
(118)
Y Chen, P Fitzgibbons, T Jacobs, G MacGrogan, H Peterse, A Vincent-Salomon, C Wa, S DeVries, E Hwang, F Waldman, S Schnitt - UCSF, San Francisco, CA; St. Jude Med Ctr, Fullerton, CA; Virginia Mason Med Ctr, Seattle, WA; Inst Bergonie, Bordeaux, France; Netherlands Cancer Inst, Amsterdam, Netherlands; Inst Curie, Paris, France; Beth Israel Deaconess Med Ctr, Boston, MA
|
| 9:00 |
Cytokeratin 5/6 Distinguishes Solid Papillary Ductal Carcinoma In-Situ from Florid Usual Ductal Hyperplasia
(203)
JT Rabban, FC Koerner, MF Lerwill - Massachusetts General Hospital and Harvard Medical School, Boston, MA
|
| 9:15 |
CK 5/6 and E-cadherin and Diagnostic Agreement in Proliferative Breast Lesions
(177)
G MacGrogan, L Arnould, S Mathoulin, A Vincent Salomon, F Bibeau, JP Ghnassia, V Picot, the GEFPICS group Institut Bergonie; Centre Leclerc; Institut Curie; Centre Val d'Aurel; Centre Strauss; des Facteurs Pronostiques Immunohistochimiques du Cancer du Sein, France - 9:30: RECESS, EXHIBITS, POSTER SESSION I
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
|
| 11:00 |
Diagnosis of Columnar Cell Change with Atypia on Breast Core Biopsy: Impact of Inter-Observer Variability, Degree of Atypia and the Volume of Lesional Changes on Surgical Management
(243)
C Xu, M Chung, D Giri - Lifespan Academic Medical Center/Brown Medical School, Providence, RI; Lifespan Academic Medical Center/Brown Medical School, Providence, RI
|
| 11:15 |
How Reproducible Is the Diagnosis of Flat Epithelial Atypia of the Breast?
(197)
FP O'Malley, S Badve, S Bose, LC Collins, M Ennis, CG Kleer, SK Mohsin, SE Pinder, SJ Schnitt - Mount Sinai Hospital, Toronto, ON; Indiana University, Indianapolis, IN; Cedars Sinai Medical Center, Los Angeles, CA; Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA; University of Toronto, Toronto, ON; University Hospital, Ann Arbor, MI; Baylor College of Medicine, Houston, TX; Addenbrooke's NHS Trust, Cambridge, UK
|
| 11:30 |
Axillary Lymph Node Dissection(ALND) in Patients with Positive Sentinel Lymph Node(SLN): Is It Needed?
(150)
S Hart-Gouleau, D Yee, T Tuttle, M Roychowdhury, C Lee, D Aslan, S Pambuccian, E Gulbahce - University of Minnesota, Minneapolis, MN
|
| 11:45 |
Array-Comparative Genomic Hybridization Analysis of Infiltrating Ductal Breast Carcinoma: Identification of Amplicons Combination Related to Desease Outcome
(237)
A Vincent-Salomon*, G Pierron*, V Raynal, N Gruel, S Liva, E Barillot, B Asselain, F Radvanyi, A Aurias, P Freneaux, V Dieras, F Reyal, X Sastre-Garau, JP Thiery, B Sigal-Zafrani, O Delattre, * equal contribution Institut Curie, Paris, France
|
|
|
